Home > Research Areas > Other Indications
Cat. No. Product name CAS No.
DC9450 (R)-Baclofen

(R)-Baclofen(STX209) is a selective GABAB receptor agonist.

69308-37-8
DCE-016 Chenodeoxycholic acid

>98%,Standard References

474-25-9
DC11919 Arimoclomol

A nontoxic heat shock protein (HSP) coinducer and potentiator of the heat shock response.

289893-25-0
DC11920 Arimoclomol maleate

A nontoxic, orally active heat shock protein (HSP) coinducer and potentiator of the heat shock response.

289893-26-1
DC11515 Azeloprazole

A novel potent proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM.

955095-45-1
DC11607 JTZ-951

A novel potent, orally active HIF prolyl hydroxylase (PHD) inhibitor with IC50 of 0.22 uM for PHD2.

1262132-81-9
DC11608 JTZ-951 hydrochloride

A novel potent, orally active HIF prolyl hydroxylase (PHD) inhibitor with IC50 of 0.22 uM for PHD2.

1262131-60-1
DC11546 Azeloprazole sodium

A novel potent, orally active proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM.

955095-47-3
DC11533 PH-46A N-Methyl-D-Glucamine salt

A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases..

1380445-04-4
DC11532 PH-46A

A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases..

1421332-97-9
DC11518 Cavosonstat

A potent, orally bioavailable inhibitor of S-nitrosoglutathione reductase (GSNOR) and CFTR modulator.

1371587-51-7
DC11519 Ceclazepide

A potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD)..

1801749-44-9
DC11688 Avacopan

Avacopan is a potent, selective, orally availale C5aR (CD88) inhibitor with IC50 of 0.1 nM.

1346623-17-3
DC11525 Mocravimod

A synthetic immunosuppressant that functions as a S1P1 receptor agonist.

509092-16-4
DC9986 Acebilustat(ZK322)

Acebilustat(ZK322) is a potent and selective leukotriene A4 hydrolase inhibitor.

943764-99-6
DC11512 Acrizanib

Acrizanib(LHA510) is a potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.

1229453-99-9
DC10234 Alosetron Hydrochloride

Alosetron Hydrochloride is the hydrochloride salt form of alosetron, a potent and selective 5-HT3 receptor antagonist.

122852-69-1
DC8584 AlviMopan

Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.

156053-89-3
DC8606 Alvimopan monohydrate

Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.

1383577-62-5
DC8605 Alvimopan dihydrate

Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.

170098-38-1
DC11076 Ampreloxetine

Ampreloxetine (TD-9855) is a potent monoamine reuptake inhibitor with pIC50 of 8.0, 8.6 and 6.8 for human NET, SERT, and DAT, respectively.

1227056-84-9
DC9034 Atomoxetine HCl

Atomoxetine Hcl(LY 139603; Tomoxetine Hcl) is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively).

82248-59-7
Page 1 / Total 6 FirstPrevNextLastGoto